Thalidomide-NH-PEG2-C2-NH2 TFA (Synonyms: Thalidomide-NH-PEG2-C2-NH2 TFA) |
Katalog-Nr.GC38949 |
Thalidomide-NH-PEG2-C2-NH2 TFA ist ein synthetisiertes E3-Ligase-Ligand-Linker-Konjugat, das den Thalidomid-basierten Cereblon-Liganden und den 2-Einheiten-PEG-Linker enthÄlt, die in der PROTAC-Technologie verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2097509-36-7
Sample solution is provided at 25 µL, 10mM.
Thalidomide-O-amido-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1].
[1]. Wang Z, et al. Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands. J Med Chem. 2019 Sep 12;62(17):8152-8163.
Average Rating: 5
(Based on Reviews and 28 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *